India says it is compliant with IPR regime; may drag US to WTO
Updated: Apr 22, 2014 12:35:03pm
New Delhi, Apr 22 (KNN) India is likely to drag the US to the World Trade Organisation on the issue of IPR if the American authorities keep insisting on slapping trade curbs on Indian products by treating New Delhi as so-called 'Priority Foreign Country'.
The stand which India is expected to take was decided at a meeting of the committee of secretaries headed by Cabinet Secretary Ajit Seth here.
Problems related to Intellectual Property Rights (IPR) with the United States, especially in the pharmaceutical sector were discussed at the high level meeting.
IPR laws in India, according to reports are fully compliant with WTO and other international norms. Thus, any unilateral decision taken by the US can amount to violation and India will not hesitate to drag the US to WTO’s dispute resolution mechanism.
In a recent development, India’s ambassador to the US has recommended that the government engage in a dialogue with US pharma companies and listen to their concerns.
Of late, according to reports, some US pharma companies have intensified pressure on their government to label India as a 'Priority Foreign Country', which may trigger adverse policy action against India.
These companies claim that India's IPR regime violates international norms and discriminates against them. (KNN/ES)
The stand which India is expected to take was decided at a meeting of the committee of secretaries headed by Cabinet Secretary Ajit Seth here.
Problems related to Intellectual Property Rights (IPR) with the United States, especially in the pharmaceutical sector were discussed at the high level meeting.
IPR laws in India, according to reports are fully compliant with WTO and other international norms. Thus, any unilateral decision taken by the US can amount to violation and India will not hesitate to drag the US to WTO’s dispute resolution mechanism.
In a recent development, India’s ambassador to the US has recommended that the government engage in a dialogue with US pharma companies and listen to their concerns.
Of late, according to reports, some US pharma companies have intensified pressure on their government to label India as a 'Priority Foreign Country', which may trigger adverse policy action against India.
These companies claim that India's IPR regime violates international norms and discriminates against them. (KNN/ES)
Loading...
